New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Regular Member

Date Joined Jan 2009
Total Posts : 390
   Posted 10/24/2009 11:23 AM (GMT -6)   
My new radiation oncologist is suggesting a phase 2 clinical trial involving an injection of Samarium 153 and beginning IMRT to bed and pelvis 12 weeks later.
My latest PSA is .7 I'm concerned that waiting would be risky given my node and seminal vesicle involvement. Anyone have any insight into this?

Age 61
Northeastern Penna.
11/08/08 annual checkup (3 yrs late) PSA 8.04 from previously 2.7 in 11/05
1/23/09 biopsy 12 cores positive, 10 cores Gleason 7, 2 cores Gleason 8 70% tumor
2/06/09 cat +bone scans clean ..
3/26/09 RRP surgery Post op path .. upgraded to Gleason 9 (5+4), seminal vesicles involved, several positive margins, 2 of 9 lymph nodes positive.
80% involved
4/4/09 Dr. advising wait for significant rise in PSA and initate hormonal treatment.
1st post op at 4 weeks PSA  .6  urologist concerned
will retest in one month
8/15/09  bone and pelvic scans redone .. clean   PSA .65
onc/radiologist recommending starting radiation treatments and 6 month shot of Lupron
9/11/09  consulting with med/onc today
Prostascint test done at U of Penna indicates cancer still confined to prostate bed.
PSA at .7
10/21/09  Rad onc suggesting clinical trial of samarium 153

New Topic Post Reply Printable Version
Forum Information
Currently it is Tuesday, September 18, 2018 7:57 PM (GMT -6)
There are a total of 3,004,458 posts in 329,148 threads.
View Active Threads

Who's Online
This forum has 161739 registered members. Please welcome our newest member, pinky;spoorback.
206 Guest(s), 9 Registered Member(s) are currently online.  Details
Tim G, logoslidat, xpeetzax, Michael_T, Sherrine, CatskillsMelanie, JaketheGreat, straydog, electrified